LU92955I2 - Rapamycine et anticorps anti-cd34 - Google Patents

Rapamycine et anticorps anti-cd34 Download PDF

Info

Publication number: LU92955I2
Authority: LU; Luxembourg
Prior art keywords: rapamycin; antibody
Prior art date: 2004-03-10

Application number

LU92955C

Other languages

English (en)

Original Assignee

Orbusneich Medical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-10

Filing date

2016-01-21

Publication date

2016-03-21

2016-01-21 Application filed by Orbusneich Medical Inc filed Critical Orbusneich Medical Inc

2016-03-21 Publication of LU92955I2 publication Critical patent/LU92955I2/fr

Links

ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
229960002930 sirolimus Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/852—Two or more distinct overlapping stents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0035—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in release or diffusion time
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
- A61F2250/0063—Nested prosthetic parts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Oral & Maxillofacial Surgery (AREA)
Engineering & Computer Science (AREA)
Transplantation (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)
Media Introduction/Drainage Providing Device (AREA)

LU92955C 2004-03-10 2016-01-21 Rapamycine et anticorps anti-cd34 LU92955I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55197804P	2004-03-10	2004-03-10
PCT/US2005/007654 WO2005086831A2 (fr)	2004-03-10	2005-03-10	Capture de cellules endotheliales progenitrices au moyen d'un dispositif medical implantable a elution medicamenteuse

Publications (1)

Publication Number	Publication Date
LU92955I2 true LU92955I2 (fr)	2016-03-21

Family

ID=34976176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92955C LU92955I2 (fr)	2004-03-10	2016-01-21	Rapamycine et anticorps anti-cd34

Country Status (9)

Country	Link
EP (2)	EP2671540B1 (fr)
JP (2)	JP5755395B2 (fr)
KR (1)	KR20060131882A (fr)
CN (2)	CN101141933B (fr)
CA (1)	CA2555364C (fr)
IL (1)	IL176784A0 (fr)
LU (1)	LU92955I2 (fr)
TW (1)	TW200539841A (fr)
WO (1)	WO2005086831A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776926B1 (en)	2002-12-11	2010-08-17	Advanced Cardiovascular Systems, Inc.	Biocompatible coating for implantable medical devices
US7758880B2 (en)	2002-12-11	2010-07-20	Advanced Cardiovascular Systems, Inc.	Biocompatible polyacrylate compositions for medical applications
US8915952B2 (en)	2004-03-31	2014-12-23	Merlin Md Pte Ltd.	Method for treating aneurysms
SG133420A1 (en) *	2005-12-13	2007-07-30	Merlin Md Pte Ltd	An endovascular device with membrane having permanently attached agents
US8500751B2 (en)	2004-03-31	2013-08-06	Merlin Md Pte Ltd	Medical device
CN104013996B (zh) *	2005-11-15	2018-02-02	奥巴斯尼茨医学公司	夺取祖内皮细胞的药物洗脱可移植的医疗设备
US7572625B2 (en) *	2006-05-18	2009-08-11	Boston Scientific Scimed, Inc.	Medical devices coated with drug carrier macromolecules
US20100063585A1 (en) *	2006-07-03	2010-03-11	Hemoteq Ag	Manufacture, method and use of active substance-releasing medical products for permanently keeping blood vessels open
CN101007187B (zh) *	2007-01-26	2014-01-01	复旦大学附属华山医院	一种复合药物洗脱支架及其药物涂层的制备方法
US20080233082A1 (en) *	2007-03-20	2008-09-25	University Of Florida	Polymer with ability to signal the recruitment of vascular progenitor cells
EP2134380A2 (fr) *	2007-03-28	2009-12-23	Boston Scientific Scimed, Inc.	Dispositifs médicaux ayant des couches bioérodables pour la libération d'agents thérapeutiques
GB0715376D0 (en) *	2007-08-07	2007-09-19	Smith & Nephew	Coating
CA2703017C (fr) *	2007-10-19	2017-04-25	Roseita Esfand	Revetements autodegradables
US8337485B2 (en) *	2008-11-04	2012-12-25	Tengion, Inc.	Cell-scaffold constructs
SG10201405144VA (en)	2009-08-26	2014-10-30	Otsuka Medical Devices Co Ltd	Medical device for placement into a lumen and manufacturing method thereof
KR101251576B1 (ko) *	2009-09-18	2013-04-08	서울대학교병원	항체 코팅 스텐트
CN102933658A (zh)	2009-12-18	2013-02-13	界面生物公司	从自组装涂层局部递送药物
JP6324371B2 (ja)	2012-04-06	2018-05-16	マーリンエムディープライベートリミテッド	動脈瘤を治療するためのデバイスおよび方法
CN102784417B (zh) *	2012-07-26	2014-06-25	江苏大学	一种冠状动脉缓释cd40单克隆抗体涂层支架
KR102409251B1 (ko)	2014-10-28	2022-06-14	가부시키가이샤 짐로	약제 용출형 스텐트
CN104758985B (zh) *	2015-03-20	2017-10-24	西南交通大学	一种捕获内皮祖细胞EPCs的新型抗凝血支架涂层的制备方法
EP4233873A3 (fr) *	2015-06-29	2023-10-18	Lyra Therapeutics, Inc.	Échafaudages implantables pour le traitement de la sinusite
US10232082B2 (en)	2015-06-29	2019-03-19	480 Biomedical, Inc.	Implantable scaffolds for treatment of sinusitis
JP6667758B2 (ja)	2015-11-26	2020-03-18	株式会社日本医療機器技研	生体吸収性ステント
CN106806948B (zh) *	2015-12-02	2020-08-25	上海微创医疗器械（集团）有限公司	PI3K/mTOR双重抑制剂的用途
CN105816921A (zh) *	2016-04-20	2016-08-03	山东百多安医用材料改性工程技术中心	一种仿生血管支架及其制备方法
US11969528B2 (en) *	2016-12-22	2024-04-30	Sino Medical Sciences Technology Inc.	Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
GB2564801B (en)	2017-04-20	2023-02-01	Lyra Therapeutics Inc	Implantable scaffolds for treatment of sinusitis
CN108926747A (zh) *	2017-05-24	2018-12-04	上海微创医疗器械（集团）有限公司	一种抗黏附多肽的应用、一种植入医疗器械及其制备方法
JP2021531061A (ja)	2018-05-22	2021-11-18	インターフェースバイオロジクス，インコーポレーテッド	薬物を脈管壁に送達するための組成物及び方法
CN111358603A (zh) *	2018-12-25	2020-07-03	元心科技(深圳)有限公司	一种药物洗脱器械及其制造方法
CN111388152B (zh) *	2018-12-27	2021-12-03	元心科技(深圳)有限公司	药物洗脱器械及其制备方法
DE102019121562B4 (de) *	2019-08-09	2024-01-11	Acandis Gmbh	Medizinische Vorrichtung zur Behandlung von Aneurysmen
KR102102660B1 (ko) *	2019-09-03	2020-04-22	(주)티제이테크	말초혈관용 스텐트의 코팅 조성액 제조 및 코팅 방법
KR20230047334A (ko) *	2020-05-27	2023-04-07	이노자임 파마, 인코포레이티드	혈관 평활근 세포 증식을 억제하기 위한 조성물 및 방법
KR102348997B1 (ko) *	2020-11-03	2022-01-07	성균관대학교산학협력단	초음파 선택적 반응 시한성 나노복합소재 기반 마찰전기 발전소자 및 이를 이용한 신경 자극 치료 장치
JP2024504175A (ja) *	2021-01-26	2024-01-30	エドワーズライフサイエンシーズコーポレイション	人工心臓弁のための３ｄ形状スカート
CN114699567B (zh) *	2022-04-15	2023-01-10	开封市卫生学校	一种可促进内皮细胞粘附和分化的体内植入物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4553974A (en) *	1984-08-14	1985-11-19	Mayo Foundation	Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4886062A (en)	1987-10-19	1989-12-12	Medtronic, Inc.	Intravascular radially expandable stent and method of implant
US5059166A (en)	1989-12-11	1991-10-22	Medical Innovative Technologies R & D Limited Partnership	Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5199939B1 (en)	1990-02-23	1998-08-18	Michael D Dake	Radioactive catheter
DE69110787T2 (de)	1990-02-28	1996-04-04	Medtronic, Inc., Minneapolis, Minn.	Intraluminale prothese mit wirkstoffeluierung.
US5302168A (en)	1991-09-05	1994-04-12	Hess Robert L	Method and apparatus for restenosis treatment
US6515009B1 (en) *	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5464450A (en) *	1991-10-04	1995-11-07	Scimed Lifesystems Inc.	Biodegradable drug delivery vascular stent
US5516781A (en)	1992-01-09	1996-05-14	American Home Products Corporation	Method of treating restenosis with rapamycin
US5288711A (en)	1992-04-28	1994-02-22	American Home Products Corporation	Method of treating hyperproliferative vascular disease
US5997517A (en)	1997-01-27	1999-12-07	Sts Biopolymers, Inc.	Bonding layers for medical device surface coatings
US6273913B1 (en)	1997-04-18	2001-08-14	Cordis Corporation	Modified stent useful for delivery of drugs along stent strut
US6541116B2 (en) *	1998-01-30	2003-04-01	Advanced Cardiovascular Systems, Inc.	Superoxide dismutase or superoxide dismutase mimic coating for an intracorporeal medical device
US6140127A (en) *	1998-02-18	2000-10-31	Cordis Corporation	Method of coating an intravascular stent with an endothelial cell adhesive five amino acid peptide
AU2001245734A1 (en) *	2000-03-15	2001-09-24	Orbus Medical Technologies Inc.	Coating that promotes endothelial cell adherence
US20030229393A1 (en) *	2001-03-15	2003-12-11	Kutryk Michael J. B.	Medical device with coating that promotes cell adherence and differentiation
CN1360951A (zh) *	2000-12-28	2002-07-31	微创医疗器械(上海)有限公司	一种具有防再狭窄涂层的血管支架
US6613083B2 (en) *	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
WO2003065881A2 (fr) *	2002-02-06	2003-08-14	Orbus Medical Technologies Inc.	Dispositif medical recouvert d'un revetement qui facilite la fixation et la differenciation de cellules endotheliales
CN1655738A (zh) *	2002-05-20	2005-08-17	奥勃斯医学技术股份有限公司	可植入的药物洗脱医疗装置
CN100413540C (zh) *	2002-09-03	2008-08-27	微创医疗器械(上海)有限公司	携载基因支架及其制备方法和应用
JP5494359B2 (ja)	2010-08-27	2014-05-14	三菱マテリアル株式会社	ヘリカルブローチ

2005
- 2005-03-10 WO PCT/US2005/007654 patent/WO2005086831A2/fr not_active Ceased
- 2005-03-10 CN CN200580004068.6A patent/CN101141933B/zh not_active Expired - Lifetime
- 2005-03-10 CA CA2555364A patent/CA2555364C/fr not_active Expired - Lifetime
- 2005-03-10 TW TW094107281A patent/TW200539841A/zh unknown
- 2005-03-10 EP EP13180123.5A patent/EP2671540B1/fr not_active Expired - Lifetime
- 2005-03-10 CN CN201510391194.7A patent/CN105078631B/zh not_active Expired - Lifetime
- 2005-03-10 KR KR1020067018528A patent/KR20060131882A/ko not_active Ceased
- 2005-03-10 JP JP2007502937A patent/JP5755395B2/ja not_active Expired - Lifetime
- 2005-03-10 EP EP05747612.9A patent/EP1753476B1/fr not_active Expired - Lifetime
2006
- 2006-07-11 IL IL176784A patent/IL176784A0/en unknown
2015
- 2015-01-29 JP JP2015016094A patent/JP5876173B2/ja not_active Expired - Fee Related
2016
- 2016-01-21 LU LU92955C patent/LU92955I2/fr unknown

Also Published As

Publication number	Publication date
EP1753476B1 (fr)	2015-07-29
CN105078631A (zh)	2015-11-25
EP1753476A4 (fr)	2011-03-09
JP2015128597A (ja)	2015-07-16
WO2005086831A2 (fr)	2005-09-22
TW200539841A (en)	2005-12-16
CN101141933B (zh)	2015-07-29
CN101141933A (zh)	2008-03-12
IL176784A0 (en)	2006-10-31
EP1753476A2 (fr)	2007-02-21
KR20060131882A (ko)	2006-12-20
EP2671540A3 (fr)	2014-06-04
CN105078631B (zh)	2017-03-08
CA2555364C (fr)	2012-10-16
CA2555364A1 (fr)	2005-09-22
EP2671540A2 (fr)	2013-12-11
EP2671540B1 (fr)	2019-10-30
JP5755395B2 (ja)	2015-07-29
WO2005086831A3 (fr)	2007-04-12
JP5876173B2 (ja)	2016-03-02
JP2007528275A (ja)	2007-10-11

Publication	Publication Date	Title
LU92955I2 (fr)	2016-03-21	Rapamycine et anticorps anti-cd34
FR25C1034I1 (fr)	2025-11-21	Anticorps ameliores selectifs de protofibrilles et leur utilisation
NO2024034I1 (no)	2024-07-15	Elvitegravir and tenofovir alafenamide
FR15C0048I2 (fr)	2015-11-20	Anticorps antagonistes de il-17
EP1940466A4 (fr)	2010-04-07	Anticorps monoclonal anti-addl et leur utilisation
EP1853718A4 (fr)	2010-01-06	Anticorps anti-cd19 et leur utilisation en oncologie
EP1765396A4 (fr)	2008-07-02	Anticorps
EP1915177A4 (fr)	2011-08-31	Anticorps d'alpha-synucléine et techniques associées
IL179140A0 (en)	2007-03-08	Antibody drug conjuates and methods
EP1718667A4 (fr)	2009-04-08	Liants et conjugues heterocycliques auto-immolateurs
EP1964852A4 (fr)	2010-02-24	Anticorps anti-ilt7
EP1810979A4 (fr)	2008-12-24	ANTICORPS IgGG4 HUMAINS STABILISES
EP1742699A4 (fr)	2012-10-17	Dispositifs interventionnels a remplacement rapide et procedes
DE602005022220D1 (de)	2010-08-19	Uhrwerk und display
EP1616881A4 (fr)	2008-08-27	Anticorps anti-mpl
DE602005002517D1 (de)	2007-10-31	Drehtisch
EP1812062A4 (fr)	2012-12-19	Anticorps anti-addl et leurs utilisations
EP1983783A4 (fr)	2011-06-01	Station mobile et station de base
EP1850873A4 (fr)	2012-06-13	Anticorps anti-tgf-beta
EP1781689A4 (fr)	2010-11-10	Conjugues et utilisations therapeutiques correspondantes
EP2056614A4 (fr)	2011-01-26	Station de base et station mobile
NO20071430L (no)	2007-05-15	Anti-OX4OL antistoffer
EP1941314A4 (fr)	2010-04-14	Agencements et techniques de microscopie
MA29039B1 (fr)	2007-11-01	Dibenzylamines et derives
ATE423121T1 (de)	2009-03-15	Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren